Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > Southern France

Please find below news from Southern France, Aquitance, Midi-Pyrénées, Corse, as well as about organisations from this region.

Total search results: 73 | Ordered by Date (descending)

order ascendingorder descendingSource order ascendingorder descendingDate
GamaMabs Pharma S.A.. (9/17/18). "Press Release: GamaMabs Pharma Starts a Phase 2 Study of Monoclonal Antibody GM102 in Patients with Advanced or Metastatic Colorectal Cancer". Paris & Toulouse. 2018-09-17
Genkyotex S.A.. (8/20/18). "Press Release: Genkyotex Secures an up to €7.5 Million Gross Financing to further Expand the Development of Its Lead Product". Archamps. 2018-08-20
Antabio S.A.S.. (7/12/18). "Press Release: Antabio Completes € 12.5m Series A. New Investors Omnes, BNP Paribas Développement and Sham Innovation Santé Invest an Additional €5.2m". Labège. 2018-07-12
Pierre Fabre S.A.. (5/18/18). "Press Release: Pierre Fabre and Roche Extend Collaboration Agreement on Companion Diagnostic Development". Castres. 2018-05-18
LNC Therapeutics. (4/17/18). "Press Release: LNC Therapeutics Appoints New CEO, Dr. Georges Rawadi, and Accelerates Development in Microbiome Research". Bordeaux. 2018-04-17
Seventure Partners. (12/14/17). "Press Release: Seventure Partners’ Microbiome Portfolio is Reaching Critical Milestones in Current and Upcoming Clinical Trials". Paris. 2017-12-14
ChemAxon Kft.. (11/21/17). "Press Release: ChemAxon and Dexstr Team Up to Boost Chemistry in Unstructured Data". Budapest, Toulouse & Boston, MA. 2017-11-21
Cerenis Therapeutics S.A.. (11/8/17). "Press Release: Cerenis Therapeutics Acquires Lypro Biosciences Expanding Its HDL Strategy into Immuno-oncology and Chemotherapeutic Drug Delivery". Toulouse & Lakeland, US. 2017-11-08
LNC Therapeutics. (9/27/17). "Press Release: LNC Therapeutics Raises € 6.5 Million and Reinforces Its R&D in the Microbiota Field". Bordeaux. 2017-09-27
Genkyotex S.A.. (8/3/17). "Press Release: Genkyotex’s GKT831 Shown to Delay Tumor Growth in Multiple Preclinical Models by Targeting Cancer Associated Fibroblasts". Archamps & Geneva. 2017-08-03
Genkyotex S.A.. (7/27/17). "Press Release: Genkyotex Provides Business Update for Q2 2017". Archamps. 2017-07-27
Eurofins Scientific. (7/10/17). "Press Release: Eurofins Has Signed an Exclusive Agreement to Acquire Amatsigroup to further Expand Its Leadership in Biopharmaceutical Services". 2017-07-10
Cerenis Therapeutics S.A.. (6/20/17). "Press Release: Bpifrance Supports the Clinical Development of CER-209 in NAFLD /NASH with a €0.75 Million Payment for Innovation". Toulouse & Ann Arbor, MI. 2017-06-20
Genkyotex S.A.. (4/27/17). "Press Release: Genkyotex Provides Business Update for Q1 2017. Cash & Cash Equivalents of €21.8 million as of March 31, 2017". Toulouse & Geneva. 2017-04-27
Transgene S.A.. (4/12/17). "Press Release: Transgene and Institut Bergonié Start the Phase 2 Part of the METROmaJX Trial". Strasbourg. 2017-04-12
Cerenis Therapeutics S.A.. (3/1/17). "Press Release: Cerenis Therapeutics Announces Top Line Results of CARAT Phase II Study. No Statistical Difference Observed between CER-001 and Placebo". Toulouse & Ann Arbor, MI. 2017-03-01
Genticel S.A.. (2/28/17). "Press Release: Genticel Announces Its 2016 Annual Results". Paris & Toulouse. 2017-02-28
Genticel S.A.. (2/28/17). "Press Release: Genticel becomes “Genkyotex”. Genticel’s General Meeting Approves the Strategic Combination with GenKyoTex SA [Not for Australia, Canada, Japan, New Zealand, South Africa or the United States]". Toulouse & Geneva 2017-02-28
Cerenis Therapeutics S.A.. (2/17/16). "Press Release: 2016 Annual Results. Solid Cash Position of €24.7 million and Finalization of CARAT Phase 2 Clinical Study". Toulouse & Ann Arbor, MI. 2017-02-17
Genticel S.A.. (12/22/16). "Press Release: Genticel and Genkyotex Announce Intention to Enter into Strategic Combination [Not for Australia, Canada, Japan, New Zealand, South Africa, or the United States]". Toulouse & Geneva. 2016-12-22
Genticel S.A.. (12/13/16). "Press Release: Genticel Reports Final Results of GTL001 Phase 2 Trial in HPV16/18-infected Women". Paris & Toulouse. 2016-12-13
Genticel S.A.. (11/30/16). "Press Release: Genticel Successfully Completes Determining Milestone in Partnership with Serum Institute Regarding Use of GTL003 in Multivalent Vaccines". Paris & Toulouse. 2016-11-30
Probiodrug AG. (11/10/16). "Press Release: Probiodrug Reports Third Quarter 2016 Business Update". Halle (Saale). 2016-11-10
Genticel S.A.. (9/22/16). "Press Release: Genticel Presents First Half 2016 Financial Results and Updates Its Operational Outlook". Paris & Toulouse. 2016-09-22
Cerenis Therapeutics S.A.. (8/30/16). "Press Release: Completion of Patient Enrolment in the CARAT Study – Meeting the Clinical Schedule". Toulouse & Ann Arbor, MI. 2016-08-30
Genticel S.A.. (7/6/16). "Press Release: Genticel Appoints Eumedix as Strategic Advisor to Support Company’s Access to Innovative Drug Candidates". Paris & Toulouse. 2016-07-06
Genticel S.A.. (6/23/16). "Press Release: Genticel Reports 18 Months Interim Analysis of GTL001 Phase 2 Trial in HPV16/18 Infected Women". Paris & Toulouse. 2016-06-23
Pierre Fabre S.A.. (6/2/16). "Press Release: The »Toulouse Cancer Santé« Foundation and the Pierre Fabre Research Institute Launch an Immuno-Oncology Research Team at the Toulouse Oncopole Campus". Toulouse & Castres. 2016-06-02
Evotec AG. (4/19/16). "Press Release: Evotec and Pierre Fabre Sign Multi-year Compound Management Agreement". Hamburg. 2016-04-19
Pierre Fabre S.A.. (4/14/16). "Press Release: Pierre Fabre Laboratories Sign a New Partnership with a Biotech Company from the Toulouse Region, VibioSphen, within the Framework of the Open Innovation Program »Nature Open Library«". Labège & Castres. 2016-04-14
Bridgepoint. (3/22/16). "Press Release: Bridgepoint Development Capital Acquires French Dental Equipment Manufacturer Acteon". 2016-03-22
Cerenis Therapeutics S.A.. (3/8/16). "Press Release: Cerenis Therapeutics Announces Its Participation to the 28th Roth Capital Partners Annual Conference". Toulouse & Ann Arbor, MI. 2016-03-08
Royal Philips. (1/29/16). "Press Release: Philips Appoints Jean Botti as Chief Innovation and Strategy Officer". Amsterdam. 2016-01-29
Genticel S.A.. (1/27/16). "Press Release: Genticel Reports Initial Results at 12 Months from Phase 2 Trial of HPV Immunoterapeutic Candidate, GTL0001". Paris & Toulouse. 2016-01-27
Genticel S.A.. (1/25/16). "Press Release: Business Update – Fourth Quarter 2015". Paris & Toulouse. 2016-01-25
Amatsigroup. (1/25/16). "Press Release: Amatsigroup Acquires Q-Biologicals and Strengthens Its Offering for International Pharmaceutical Groups". Toulouse. 2016-01-25
Toulouse White Biotech (TWB). (1/19/16). "Press Release: TWB and AMOEBA – Towards the Industrialization of a Revolutionary Biological Biocide against Legionella". Toulouse. 2016-01-19
Evotec AG. (1/7/16). "Press Release: Evotec and UCB Sign Multi-year Sample Management Agreement". Hamburg. 2016-01-07
Genticel S.A.. (1/7/16). "Press Release: Genticel to Evaluate Roche Molecular Systems’ cobas HPV Test in Preparation for Phase 3 Porgram of GTL001". Paris & Toulouse. 2016-01-07
Genticel S.A.. (1/5/16). "Press Release: Genticel Appoints Rémi Palmantier, PhD, as Chief Scientific Officer to Accelerate Its Development". Paris & Toulouse. 2016-01-05
GamaMabs Pharma S.A.. (12/15/15). "Press Release: GamaMabs Pharma Raises €15m in Series B Financing Round". Toulouse & Paris. 2015-12-15
Toulouse White Biotech (TWB). (11/26/15). "Press Release: TWB Announces the Creation of EnobraQ, Specialist in CO2 Capture and Exploitation Using Yeast". Toulouse & Paris. 2015-11-26
Genticel S.A.. (9/21/15). "Press Release: Genticel Presents First Half 2015 Financial Results, Operational Progress and Outlook". 2015-09-21
Genticel S.A.. (9/8/15). "Press Release: US Patent Granted for Use of Genticel’s Antigen Delivery Vectors in Combination Therapy to Treat Cancer". Paris & Toulouse. 2015-09-08
Genticel S.A.. (9/1/15). "Press Release: Genticel to Meet Investors". Paris & Toulouse. 2015-09-01
Genticel S.A.. (7/2/15). "Press Release: Genticel CFO, Martin Koch, Appointed CEO to Replace Benedikt Timmerman during Temporary Medical Leave of Absence". 2015-07-02
Genticel S.A.. (4/9/15). "Press Release: Genticel Strengthens Management Team and Appoints Valerie Leroy as Senior Director, Corporate Communications and Investor Relations". Paris & Toulouse. 2015-04-09
Cerenis Therapeutics S.A.. (3/25/15). "Press Release: Outstanding Success of Cerenis Therapeutics’ IPO with €53.4 Million Raised on Euronext Paris [Not for United States, Canada, Australia or Japan]". Toulouse & Ann Arbor, MI. 2015-03-25
Evotec AG. (3/20/15). "Press Release: Evotec and Sanofi Sign Definitive Agreement for Major Multi-component Strategic Alliance. Total Deal Value of EUR 250 m, including more than EUR 40 m Upfront Cash Payment". Hamburg. 2015-03-20
Genticel S.A.. (2/2/15). "Press Release: Genticel Licenses Vaxiclase Platform to Serum Institute of India for Use in Pertussis Vaccines". Paris & Toulouse. 2015-02-02
Curie-Cancer. (12/16/14). "Press Release: Curie-Cancer and GamaMabs Pharma Renew Their Research Partnership to Develop an Antibody for Gynecological Cancers". Paris & Toulouse. 2014-12-16
Evotec AG. (12/2/14). "Press Release: Evotec and Sanofi Enter Into Exclusive Negotiations for a Major Multi-component Strategic Collaboration. Expect to Sign the Transaction in H1 2015". Hamburg. 2014-12-02
GamaMabs Pharma S.A.. (11/27/14). "Press Release: GamaMabs Pharma Signs a Collaboration Agreement with Mayo Clinic". Toulouse. 2014-11-27
Vexim S.A.. (9/22/14). "Press Release: Vexim Announces Strong 2014 Half-year Results". Toulouse. 2014-09-22
Vexim S.A.. (9/8/14). "Press Release: Vexim Opens U.S. Subsidiary. Office to Support Vexim’s Product Portfolio Launch in the U.S.". Toulouse. 2014-09-08
Vexim S.A.. (4/15/14). "Press Release: Vexim Doubles Its Sales in the 1st Quarter of 2014, to €2.1m". Toulouse. 2014-04-15
Genticel S.A.. (4/4/14). "Press Release: Genticel Lists on Euronext in Paris and Brussels". 2014-04-04
Redx Pharma Ltd.. (3/6/14). "Press Release: Redx Strikes Skin Cancer Deal with French Pharma Giant". Castres & Liverpool. 2014-03-06
GamaMabs Pharma S.A.. (3/3/14). "Press Release: GamaMabs Pharma Announces Two Financings Totaling €1.1 Million". Toulouse. 2014-03-03
Agilent Technologies Inc.. (1/16/14). "Press Release: Agilent Technologies Announces Agreement with Picometrics Technologies to Offer CE-LIF, CE-LIF-MS Solutions for Biopharmaceutical Applications". Santa Clara, CA. 2014-01-16
Adocia S.A.. (12/9/13). "Press Release: Adocia Signs an Exclusive License on a Nanotechnology which Improves the Efficacy of Anti-tumoral Agents by Targeting Their Action into Tumors". Lyon. 2013-12-09
GamaMabs Pharma S.A.. (9/30/13). "Press Release: Funding of a New French Biotechnology Company Specialized in Cancer. LFB S.A. and Bpifrance Announce the Creation of GamaMabs Pharma". Paris. 2013-09-30
Genticel S.A.. (4/24/13). "Press Release: Genticel Secures EUR 18.2 Million (USD 23.7 Million) in Capital Funding". Toulouse. 2013-04-24
Scienion AG. (3/25/13). "Press Release: Scienion and Innopsys Agree on a Joint Product Offering for Reverse Phase Protein Arrays. Added Value for Customers Combining Technologies of both Companies into a Complete Assay Solution". Dortmund & Berlin. 2013-03-25
Argenta. (2/7/13). "Press Release: Argenta and Antabio Announce Drug Discovery Collaboration". Harlow & Labège. 2013-02-07
Cerenis Therapeutics S.A.. (11/22/11). "Press Release: The Board of Cerenis Appoints Dr. Richard C. Pasternak as Non Executive Director. Internationally Recognized Expert Brings over 30 Years of Experience in the Field of Cardiovascular Disease". Toulous 2011-11-22
Cerenis Therapeutics S.A.. (11/22/11). "Press Release: Cerenis Appoints John F. Paolini as Chief Medical Officer. Internationally Recognized Expert Brings over 15 Years of Experience in Drug Development and Commercialisation to Treat Cardiovascular Disea 2011-11-22
Photonis Holding S.A.S.. (9/7/11). "Press Release: Axa Private Equity Acquires Photonis from Astorg Partners". Paris. 2011-09-07
bioMérieux S.A.. (7/19/11). "Press Release: bioMérieux Expands Its Infectious Disease Offering with Acquisition of Argene, Specialized in Molecular Diagnostics for Immunocompromised Patients". Marcy l’Étoile. 2011-07-19
Cerenis Therapeutics S.A.. (10/21/10). "Press Release: Cerenis Therapeutics Raises Additional €10 Million to Close €50 Million Series C Financing". 2010-10-21
Cerenis Therapeutics S.A.. (7/26/10). "Press Release: Cerenis Therapeutics Raises EUR 40 Million in Series C Financing. Jean-Pierre Garnier Appointed as Non-executive Director to the Board". Toulouse & Ann Arbor, MI. 2010-07-26
Cerenis Therapeutics S.A.. (2/10/09). "Press Release: Cerenis Therapeutics Receives €2.5 Million Investment from French Government through OSEO". Toulouse & Ann Arbor, MI. 2009-02-10
Cerenis Therapeutics S.A.. (2/3/09). "Press Release: Cerenis Therapeutics In-licenses Intellectual Property for New Treatment of Aortic Valve Stenosis. Intellectual Property Based on Breakthrough Research from a Team Led by Dr. Jean-Claude Tardif at the 2009-02-03




Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top